Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Qingdao Ligeance Chemistry is a specialized chemical manufacturer based in China that focuses on the production of high-purity reagents and intermediates for the life sciences industry. The company is a key supplier of nucleosides, nucleotides, and phosphoramidites, which are essential building blocks for oligonucleotide synthesis and RNA-based therapeutics. They provide custom synthesis and contract manufacturing services to pharmaceutical and biotechnology companies globally. Their expertise lies in complex organic synthesis and large-scale production of modified nucleosides. By supporting the development of antisense and siRNA drugs, the company plays a critical role in the modern genomic medicine supply chain. They are recognized for their ability to provide high-quality materials that meet the stringent requirements of pharmaceutical R&D.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Qingdao Ligeance Chemistry.